Oxford Global Conferences are proud to present the 2ndAnnual Stem Cell Congress, taking place on the 9th & 10th November 2015 in London, United Kingdom. This event will be co-located with our prestigious 4th Annual Cell Culture & Bioprocessing Congress, as well as our new Cell and Gene Therapy Congress.
The global stem cell market is set to reach a value of well over $100 billion by 2019, with stem cell therapies alone surpassing an estimated $330 million by 2020. Stem cells are likely to be central to the future of medicine, and as the potential for medical applications progresses we are seeing an ever-increasing interest in stem cell research in industry as well as academia. Over two days, the Stem Cell Congress will give attendees the opportunity to hear from those at the forefront of stem cell research share their knowledge on current challenges and exciting developments, as well as the insights into the future of the industry.
The first day of the conference will look at the latest innovations in stem cell bioprocessing, including challenges with the upstream and downstream stages, meeting quality requirements, and efficient cell banking practices. Experts from academia, pharmaceutical and biotech organisations will present on the key topics in the industry today, ranging from novel reprogramming and transdifferentiation techniques, to the most effective methods to engineer mammalian stem cells or ensure controlled growth.
The second day of the Stem Cell Congress will address the major issues and opportunities in the field of stem cell therapies, including up to date clinical trial information and approaches to commercialisation. Our highly experienced panel will discuss key topics including techniques to build truly effective clinical trials and exciting insights into optimising delivery of stem cell therapies.
Over two days, the congress will attract senior-level decision makers working at the cutting edge of the stem cell industry from the US and Europe. The programme consists of world-class keynote addresses, industry and academic led presentations and panel debates, as well as ample networking opportunities, creating an ideal interactive platform for high-level scientific and business discussion.
Executive Director, Integrative Research, Celgene
CEO, Juventas Therapeutics
Associate Professor, StemBANCC
Reader in Tissue Engineering & Cell Therapy, University of Reading
Professor, Imperial College London
Head, Stem Cell Based Assay Development (SCADEV) Platform & Group Leader, Stem Cells in Neural Development & Disease Lab, Helmholtz Zentrum München
Professor, University of Bern
Fellow, Cell Therapy, Novartis Biologics
Professor, Imperial College London
Reader in Stem Cell Science, King’s College London
Head of Engineering, ReNeuron
President, Plymouth University
Professor for Cellular and Developmental Biology, University of Luxembourg
Professor of Molecular Stem Cell Biology, LUMC
Professor, Norwegian Stem Cell Centre, University of Oslo
Principal Research Associate, University College London
Jens Vinge Nygaard
Head of Section & Associate Professor, Aarhus University
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of 40 speakers will present a full conference programme covering the topics outlined below.
Day 1 – Stem Cell & iPSC Bioprocessing & Manufacturing
- Cell manufacturing: meeting quality, quantity & safety requirements
- Overcoming upstream & downstream process challenges
- Stem cell engineering: ensuring automation & validation
- Reprogramming & transdifferentiation techniques
- Ensuring controlled growth & differentiation
- Cell banking to preserve stem cell lines
- Developing 3D tissue culture technology
Day 2 – Stem Cell Therapy: Clinical & Commercialisation
- Designing clinical trials for stem cell therapies
- Streamlining the delivery of stem cell therapies
- Innovations in tissue engineering & organ regeneration
- Regulatory issues: developing safe & effective treatments
- Genome editing of human pluripotent stem cells for disease modelling
- The future of clinical trials and commercialisation
Submit a poster
For attendees interested in submitting a poster, there are opportunities now available. Your poster presentation will be located in the exhibition room for two days alongside other posters from senior scientists working in industry and academia.
How to submit your abstract
We will require:
- Poster title, Abstract (200 words or less)
- Principal author, Organisation
- Mailing address, Email, Telephone, Fax
- Additional authors
In order to secure your board space a fee of £250 plus VAT will be required. The poster should be presented as A0 (841mm x 1189mm) portrait size.To take advantage of this opportunity you need to be registered as a paid delegate over the 2 days. We have limited spaces available, so please register soon!